ArticleBioinformatics (Oxford, England)2026
A spectrum of gut microbiota signatures predicts long-term health status.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
motivationThe human gut microbiota is a complex ecosystem composed of hundreds of unique microbial species in a typical adult individual. Its composition has been linked to an individual's current and future health. At the population level, joint analysis of co-abundant species can capture associations with health status and other variables that cannot be robustly detected by analyzing individual taxa alone. Recently, the concept of enterosignatures was proposed to detect such co-abundant groups, decomposing microbial community variation into a mixture of five broad components of co-varying microbial taxa. However, their overall robustness, generalizability, and prospective potential in predicting long-term health status remain to be evaluated.
resultsWe demonstrate that robust signatures of co-abundant species can be prospectively associated with mortality, diabetes, liver disease, and sepsis risk among Finnish adults in the FINRISK population cohort based on a 20-year follow-up. We characterized dysbiosis-associated signatures across varying levels of sub-ecosystem granularity, encompassing a previously reported Escherichia-driven signature as well as novel Prevotella subspecies-driven signatures linked to compromised future health status. These results illustrate the benefits of analyzing latent signatures across multiple levels of ecosystem granularity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.